Loading clinical trials...
Loading clinical trials...
Preliminary studies have suggested that non-invasive methods can not only be applied to CSPH but also to predict the risk of decompensation in cirrhosis. However, there is a lack of clinical evidence,...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Nanfang Hospital, Southern Medical University
NCT07268196 · Chronic Liver Disease and Cirrhosis
NCT06163001 · Chronic Liver Disease and Cirrhosis, Frailty
NCT05407272 · Alzheimer Disease, Late Onset, Stroke, and more
NCT05163132 · Chronic Hepatic, Chronic Liver Disease and Cirrhosis
NCT04103840 · Severe Alcoholic Hepatitis, Chronic Liver Disease and Cirrhosis
Nanfang Hospital of Southern Medical University
Guangzhou, Guangzhou
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions